Modern antipsychotic drugs: a critical overview

Gardner, David M.; Baldessarini, Ross J.; Waraich, Paul
June 2005
CMAJ: Canadian Medical Association Journal;6/21/2005, Vol. 172 Issue 13, p1703
Academic Journal
Abstract CONVENTIONAL ANTIPSYCHOTIC DRUGS, used for a half century to treat a range of major psychiatric disorders, are being replaced in clinical practice by modern "atypical" antipsychotics, including aripiprazole, clozapine, olanzapine, quetiapine, risperidone and ziprasidone among others. As a class, the newer drugs have been promoted as being broadly clinically superior, but the evidence for this is problematic. In this brief critical overview, we consider the pharmacology, therapeutic effectiveness, tolerability, adverse effects and costs of individual modern agents versus older antipsychotic drugs. Because of typically minor differences between agents in clinical effectiveness and tolerability, and because of growing concerns about potential adverse long-term health consequences of some modern agents, it is reasonable to consider both older and newer drugs for clinical use, and it is important to inform patients of relative benefits, risks and costs of specific choices.


Related Articles

  • Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe. Bowers, Len; Callaghan, Patrick; Clark, Nicola; Evers, Catharine // European Journal of Clinical Pharmacology;Mar2004, Vol. 60 Issue 1, p29 

    Objective. To compare prescribed daily doses (PDDs) of psychotropic drugs in several European centres. Method. A one-day census of psychotropic drug prescriptions to 613 patients in 39 acute psychiatric wards in ten countries. Results. Patients in Spain were on most drugs; patients in Germany...

  • Atypical Antipsychotic Agents Not Safer or More Effective.  // Journal of Psychosocial Nursing & Mental Health Services;Nov2005, Vol. 43 Issue 11, p8 

    Highlights the result of a study on the efficacy of new antipsychotic drugs, published in the "New England Journal of Medicine." Findings that perphenazine is as effective and safe as more expensive antipsychotic agents; Comparisons of the efficacy of newly developed and older, less expensive...

  • Assessing Psychiatric Adverse Effects during Clinical Drug Development. Rudorfer, Matthew V.; Hillefors, Mi // Pharmaceutical Medicine - New Zealand;2012, Vol. 26 Issue 6, p363 

    Throughout the phases of drug development, safety as well as efficacy measures are important to evaluate. Although it is well established that many types of medications that affect the central nervous system can influence emotional regulation and cognitive functioning, attention to potential...

  • Antipsychotics.  // Reactions Weekly;Apr2014, Vol. 1497 Issue 1, p7 

    The article presents case studies of two men and a woman with neuroleptic-induced deficit syndrome which developed while receiving the antipsychotics haloperidol, blonanserin, risperidone, fluphenazine, and olanzapine for their respective diseases.

  • A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses. Chagnon, Y. C.; Mérette, C.; Bouchard, R. H.; Émond, C.; Roy, M.-A.; Maziade, M. // Molecular Psychiatry;Dec2004, Vol. 9 Issue 12, p1067 

    Antipsychotics can induce in schizophrenic (SZ) and bipolar disorder (BP) patients serious body weight changes that increase risk for noncompliance to medication, and risk for cardiovascular diseases and diabetes. A genetic origin for this susceptibility to weight changes has been hypothesized...

  • A Double-Edged Sword: Atypical Antipsychotics in Child and Adolescent Psychiatry. Kowatch, Robert A. // Child & Adolescent Psychopharmacology News;Nov2003, Vol. 8 Issue 7, p4 

    The article focuses on the use of atypical antipsychotic agents in child and adolescent psychiatry in the U.S. It mentions that psychiatrists use the agents which include clozapine, risperidone and olanzapine because of their efficacy but studies on their long-term effects on brain development,...

  • Psicofarmacología sensible al sexo: influencia del sexo en el tratamiento farmacológico de los trastornos psiquiátricos.  // Actas Espanolas de Psiquiatria;sep2004, Vol. 32 Issue 5, p307 

    Gender-based pharmacology is a new research and clinical area which could be defined by the inclusion of gender-related variables in clinical, research and educational issues with respect to pharmacotherapy. Most of the studies which have studied pharmacokinetic gender differences in...

  • Possible Link Explored Between Antipsychotics And Several Conditions.  // RN;Jun2004, Vol. 67 Issue 6, p76 

    Explores the possible link between antipsychotics and several conditions. Recommendation for monitoring closely on patients who take antipsychotics for signs that they are developing diabetes, obesity, or high cholesterol; Emergence of the consensus statement made by the American Diabetes...

  • Quetiapine.  // Reactions Weekly;12/9/2006, Issue 1131, p30 

    The article presents a case report of a female patient who developed erythema multiforme minor during treatment with quetiapine for schizophrenia, with reference to a study by G.-L. Lin, C.-H. Chiu and S.-K. Lin in the December 2006 issue of the "Journal of Clinical Psychopharmacology." Her...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics